Amgen Inc.
ANTIBODIES TO OPGL
Last updated:
Abstract:
Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described.
Status:
Application
Type:
Utility
Filling date:
9 Jan 2020
Issue date:
30 Apr 2020